Delivery Order SPE2DB22D1017-SPE2DB25FE9DW

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $7,770.14 and an ultimate completion date of March 31, 2025. It is a delivery order contract for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S, with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,985.36 firm fixed-price delivery order covers the supply of RYTARY ER 36.25 MG-145 MG capsules in 100-count packages. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,559.24, is a firm fixed-price delivery order for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S. The contract has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,810.58 firm fixed-price delivery order is for the pharmaceutical product RYTARY ER 48.75 MG-195 MG CAP 100S. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.88 firm fixed-price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a performance period through March 16, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,337.54 firm fixed-price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,155.82, is a delivery order for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $6,779.60, is a firm fixed price delivery order for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $26,434.98. It is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $5,737.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, to DLA Troop Support Medical. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is a Delivery Order under a larger Indefinite Delivery...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9DW
    Delivery Order

The federal contract award is for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order valued at $7,762.59 with a firm fixed price. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:16 PM